New study: Break-through treatment option to help millions treat eczema
A new study confirms that Staphefekt™ significantly reduces eczema symptoms
A new ground-breaking study, conducted by Gladskin has clinically proven that their products, containing the active ingredient Staphefekt™ alleviate eczema symptoms and improve quality of life in children and adults.
- 65% of people showed significant symptom improvement in 3 days.
- 91% showed significant symptom improvement by the end of 1 week, after two weeks, itching was reduced by half, tingling by 63%, and burning sensations were reduced by 79%.
- 100% of children and 95% of adults reported a significantly improved quality of life at the end of two weeks, with sleep deprivation reduced by 74%.
Read more about the study in our blog
Gladskin Eczema Cream & Gel
Contains active enzyme Staphefekt™
Reduces itch and redness
Hypoallergenic and dermatologically tested
Recommended for dry skin
Safe and suitable for daily use
Gladskin and the skin microbiome
Eczema can be caused by different factors: skin barrier defects, an overreacting immune response or a skin microbiome imbalance due to an over-colonization of bad bacteria called Staphylococcus aureus:
Gladskin, is the first product to contain the active ingredient Staphefekt™, an enzyme that selectively removes the bad bacteria from the microbiome, whilst leaving the good bacteria unharmed. This approach helps to restores the balance of bacteria so the skin can heal.
The health advice on this website is not intended to replace medical diagnosis or treatment by a doctor. In the case of acute health problems, always consult a physician.